Stocks and Investing
Stocks and Investing
Thu, March 21, 2024
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
Stephen Willey Maintained (VOR) at Strong Buy with Decreased Target to $12 on, Mar 21st, 2024
Stephen Willey of Stifel, Maintained "Vor Biopharma Inc." (VOR) at Strong Buy with Decreased Target from $15 to $12 on, Mar 21st, 2024.
Stephen, nor any peers, have made any analyst calls on VOR in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources